GlassScriptPhysician profile
Luke O Nichols
NPI 1013947530
$859.87
in general payments reported to CMS, 2019-2025
16 companies · $161 in 2025
The $161 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2022: $103 · 2023: $126 · 2024: $275 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $356.28 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $197.67 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.90 | 2019 | |
| Pfizer INC. | $33.99 | 2023 | |
| Shire North American Group INC | $28.32 | 2019 | |
| Glaxosmithkline, LLC. | $25.00 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.68 | 2019 | |
| Cranial Technologies, INC | $24.18 | 2025 | Doc Band |
| Kyowa Kirin, INC. | $22.13 | 2025 | |
| Sobi, INC | $21.90 | 2019 | |
| Biogen, INC. | $19.04 | 2025 | Skyclarys |
| Collegium Pharmaceutical, INC. | $18.23 | 2025 | Jornay Pm |
| Vertical Pharmaceuticals, LLC | $14.92 | 2024 | Relexxii |
| Novo Nordisk INC | $14.44 | 2023 | |
| Merck Sharp & Dohme LLC | $11.69 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $11.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Nichols listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.